Marion Rowland Source Confirmed

OverviewAI-generated summary

Marion Rowland's research focuses on pediatric health, with a significant emphasis on cystic fibrosis and liver disease. Their work includes a systematic review examining the impact of liver disease on mortality in cystic fibrosis patients and a prospective cohort study on the natural history of cystic fibrosis liver disease. Rowland has also investigated the effects of specific therapies on liver function tests in pediatric patients with cystic fibrosis receiving lumacaftor/ivacaftor treatment.

Beyond cystic fibrosis, Rowland has contributed to updated guidelines for the management of *Helicobacter pylori* infection in children and adolescents. Their recent publications also extend to animal science, with studies on the use of probiotics in broiler chickens to mitigate enteric colonization by pathogens and manage microbial blooms during hatching. Additionally, Rowland has explored the health behaviors of adolescents nearing adulthood in North East England.

With 81 publications and over 3,600 citations, Rowland is recognized as a highly cited researcher. They have collaborated with several researchers at the University of Arkansas at Fayetteville, including Danielle M. Graham, Christine N. Vuong, Aaron Forga, and Billy M. Hargis.

Metrics

• h-index: 29
• Publications: 81
• Citations: 3,625